Net Deals Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Siponimod - Wikipedia

    en.wikipedia.org/wiki/Siponimod

    Siponimod. Siponimod, sold under the brand name Mayzent, is a selective sphingosine-1-phosphate receptor modulator for oral use that is used for multiple sclerosis (MS). [ 8] It is intended for once-daily oral administration. [ 10][ 8] In March 2019, it was approved in the United States to treat adults with relapsing forms of multiple sclerosis ...

  3. Eltrombopag - Wikipedia

    en.wikipedia.org/wiki/Eltrombopag

    Eltrombopag, sold under the brand name Promacta among others, is a medication used to treat thrombocytopenia (abnormally low platelet counts) and severe aplastic anemia. [ 3][ 4] Eltrombopag is sold under the brand name Revolade outside the US and is marketed by Novartis. [ 5] It is a thrombopoietin receptor agonist. [ 3]

  4. Brolucizumab - Wikipedia

    en.wikipedia.org/wiki/Brolucizumab

    Brolucizumab was designed to attach to and block a substance called vascular endothelial growth factor A (VEGF-A). [6] VEGF-A is a protein that makes blood vessels grow and leak fluid and blood, damaging the macula. By blocking VEGF-A, brolucizumab reduces the growth of the blood vessels and controls the leakage and swelling.

  5. US FDA approves Novartis' kidney disease drug - AOL

    www.aol.com/news/us-fda-approves-novartis-kidney...

    By Sriparna Roy. (Reuters) -The U.S. Food and Drug Administration has approved the use of Novartis' drug to reduce excess protein in the urine of patients with a type of kidney disease, the health ...

  6. Novartis, Viatris face new lawsuit over 'HeLa' cell misuse claims

    www.aol.com/news/novartis-viatris-face-lawsuit...

    Novartis and Viatris were hit with a federal lawsuit in Maryland on Monday by the family of a woman whose tissue cells were taken from her body in the 1950s and used to fuel medical research and ...

  7. US FDA approves Adaptimmune's therapy for rare type of cancer

    www.aol.com/news/us-fda-approves-adaptimmunes...

    By Mariam Sunny. (Reuters) -The U.S. Food and Drug Administration said on Friday it has approved Adaptimmune's first-of-its-kind treatment for a rare type of cancer in the soft tissues that most ...

  8. Novartis Gene Therapies - Wikipedia

    en.wikipedia.org/wiki/Novartis_Gene_Therapies

    Novartis Gene Therapies, until 2020 known as AveXis, is a biotechnology company that develops treatments for rare neurological genetic disorders. It was founded in Dallas , Texas , United States in 2012 by John Carbona after reorganizing a company called BioLife Cell Bank founded by David Genecov and John Harkey.

  9. Novartis - Wikipedia

    en.wikipedia.org/wiki/Novartis

    Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022. [ 4][ 5] Novartis manufactures the drugs clozapine (Clozaril), diclofenac (Voltaren; sold to ...